A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
Tekijät: Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M, Norgaard M, Nielsen RB, Zoega H, Valdimarsdottir U
Kustantaja: AMER MEDICAL ASSOC
Julkaisuvuosi: 2013
Journal: JAMA: Journal of the American Medical Association
Tietokannassa oleva lehden nimi: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Lehden akronyymi: JAMA-J AM MED ASSOC
Vuosikerta: 309
Numero: 1
Aloitussivu: 48
Lopetussivu: 54
Sivujen määrä: 7
ISSN: 0098-7484
DOI: https://doi.org/10.1001/jama.2012.153812
Tiivistelmä
Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.
Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.
Turun yliopiston Tutkimustietojärjestelmän portaali